Averion International opens office in Ukraine
This article was originally published in Scrip
Averion International, the Boston-based CRO specialising in oncology, dermatology and nephrology, has opened an office in Kiev, Ukraine, and appointed Dr Evgeny Levenko its head. It conducts several oncology and cardiology studies in Ukraine, and their number might be expanded in the next few months, the company said. It hopes to benefit from the country's large patient populations, motivated investigators and a large number of medical universities and academic institutions. Opening the new office follows the company's expansion last year when it opened offices in Germany, the UK, Austria and Poland.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.